Bristol-Myers Squibb Rights
CELG.RT
21 hedge funds and large institutions have $164K invested in Bristol-Myers Squibb Rights in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0.03% → 0.03% (-0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
5% less funds holding
Funds holding: 22 → 21 (-1)
46% less capital invested
Capital invested by funds: $303K → $164K (-$139K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MS
Maven Securities
St Helier,
Jersey
|
+$12.7K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.75K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$217 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$177K |
| 2 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$2.81K |
| 3 |
DC
Davenport & Co
Richmond,
Virginia
|
-$343 |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$271 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$4 |
CELG.RT Hedge Fund Activity: Q4 2021 in Review
21 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Rights (CELG.RT) for Q4 2021, worth a combined $164K — down 46% from $303K a quarter earlier.
Fund positioning in CELG.RT was balanced in Q4 2021: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 4 trimmed.
The largest buyer was Maven Securities, opening a new position worth an estimated $12.7K. The largest seller was Boothbay Fund Management, exiting entirely with an estimated $177K sold.
- 21 institutional investors held Bristol-Myers Squibb Rights (CELG.RT) as of Q4 2021, down from 22 in Q3 2021.
- Funds reported $164K of Bristol-Myers Squibb Rights stock for Q4 2021, down 46% quarter-over-quarter.
- 3 funds opened new Bristol-Myers Squibb Rights positions in Q4 2021 and 3 closed out, a net change of 0 holders.
- The largest Bristol-Myers Squibb Rights buyer in Q4 2021 was Maven Securities, an estimated $12.7K added.
- The largest Bristol-Myers Squibb Rights seller in Q4 2021 was Boothbay Fund Management, an estimated $177K sold.
Based on aggregated 13F filings for Q4 2021.